About Us | Contact

Allan C Halpern

NPI1093786881
Update NPI

Open Payments

Note

The following payment details are based on a national transparency program known as the Sunshine Act that collects and publishes information about financial relationships between the health care industry (i.e. drug and device manufactures) and providers. These relationships may involve payment to providers for things such as research, speaking engagment, travel, gifts etc. Not all of these payment involve monetary compensations and may include batering of drugs or devices.

Total Payment Worth

$23,833.58
from 10 payments in the last 6 years

Total Cash or Cash Equivalent

$23,600.00
from 8 payments in the last 6 years

Total In-kind Items & Services

$233.58
from 2 payments in the last 6 years

Nature of Payments

Last 6 Years
Chart will render here...

Yearly Breakdown

Chart will render here...

Payment Details

Date Payment Type Form of Payment Item/Service Payment Amount
11/09/2016 General (Non-Research) Cash or cash equivalent Consulting Fee $3500.00 Details
Payment from F. Hoffmann-La Roche AG
Payment Record ID 513166273
11/09/2016 General (Non-Research) In-kind items and services Food and Beverage $110.20 Details
Payment from Genentech, Inc.
Payment Record ID 513165319
05/18/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $2100.00 Details
Payment from F. Hoffmann-La Roche AG
Payment Record ID 488303619
02/16/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $2100.00 Details
Payment from F. Hoffmann-La Roche AG
Payment Record ID 488196877
03/14/2017 Research Cash or cash equivalent Drug $2100.00 Details
Payment from Genentech, Inc.
Paymment Research Study Longitudinal Evaluation of 18FGTP1 as a PET Radioligand for Imaging Tau in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants
Payment Record ID 485523015
06/15/2017 Research Cash or cash equivalent Drug $2100.00 Details
Payment from Genentech, Inc.
Paymment Research Study Longitudinal Evaluation of 18FGTP1 as a PET Radioligand for Imaging Tau in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants
Payment Record ID 485473041
03/24/2017 General (Non-Research) Cash or cash equivalent Consulting Fee $7500.00 Details
Payment from Janssen Research & Development, LLC
Payment Record ID 447609283
01/27/2016 General (Non-Research) In-kind items and services Food and Beverage $123.38 Details
Payment from Anacor Pharmaceuticals, Inc.
Payment Record ID 404440822
02/23/2016 Research Cash or cash equivalent Drug $2100.00 Details
Payment from Genentech, Inc.
Paymment Research Study Genentech Derm CEVABIOS
Payment Record ID 402951804
05/05/2016 General (Non-Research) Cash or cash equivalent Consulting Fee $2100.00 Details
Payment from Genentech, Inc.
Payment Record ID 402900234
;